Theriva Biologics Announces 1-for-30 Reverse Stock Split Effective Dec. 1

PUBT · 22h ago
Theriva Biologics Announces 1-for-30 Reverse Stock Split Effective Dec. 1
  • Theriva Biologics will implement a 1-for-30 reverse stock split effective at 11:59 p.m. Eastern Time on Dec. 1, 2026.
  • Split-adjusted trading begins Dec. 2, 2026, on NYSE American. The split aims to meet the exchange's per-share price requirements.
  • Outstanding common shares will decline from 45,892,668 to approximately 1,529,756, excluding fractional-share adjustments.
  • Authorized common shares will decrease from 350,000,000 to 11,666,666.
  • Fractional shares will be rounded up to the next whole share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theriva Biologics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611201635PRIMZONEFULLFEED9882472) on November 20, 2026, and is solely responsible for the information contained therein.